Join
Live feed
·
INSIDERFilingvia Quantisnow
Immunovant Inc. logo

Chief Executive Officer Salzmann Peter sold $364,941 worth of shares (28,094 units at $12.99), decreasing direct ownership by 2% to 1,186,512 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IMVT· Immunovant Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMVT (Immunovant Inc.) and more on Quantisnow.